The widespread adoption of weight-loss medications such as Ozempic, Wegovy, and Mounjaro has ushered in a new wave of consultations for cosmetic surgeons, as individuals seek to manage the physical aftermath of rapid weight reduction. Doctors report that breast augmentation and reshaping procedures are now the most frequent requests, with other areas like the abdomen, face, arms, and thighs also targeted for surgical correction.
This trend, dubbed the 'Ozempic body' by some in the aesthetic medicine field, reflects a shift from the initial focus on weight loss to addressing the bodily changes that follow. According to one plastic surgery nurse, approximately 40% of patients seeking consultations are looking to correct the impact of these GLP-1 medications.
Factors such as age, genetics, and skin elasticity influence how an individual's skin responds to rapid fat loss. Younger patients or those with naturally thicker, darker skin tones may find their skin retains more of its elasticity. However, older individuals or those with thinner, fairer skin may experience a permanent loss of skin support, leading to loose, deflated tissue that exercise cannot address.
For women, the effects on breasts can be particularly noticeable. Due to their composition of fatty tissue, breasts often decrease in volume as weight-loss medications take effect. This can lead to a phenomenon described as 'Ozempic breast,' characterized by a deflation of the upper breast area, causing it to sag downward and appear flat above the nipple. The skin in the chest and arm area may also become stretched and thin, complicating reshaping and lifting procedures.
While patients are increasingly seeking to refine their physiques, the preference in breast augmentation has shifted away from overly large implants. Instead, there is a growing demand for smaller, more natural-looking enhancements, often referred to as 'ballerina boobs.' This aligns with the goal of restoring lost volume rather than achieving a dramatic increase in size. Some patients opt for smaller implants, in the range of 200cc, a departure from the historical average of over 300cc.
Discretion surrounding both GLP-1 usage and cosmetic procedures is common, with some patients keeping their surgeries secret even from close family members. Advancements in surgical techniques are also contributing to a more streamlined patient experience. Modern methods can reduce recovery times, with some patients able to go home the same day as their procedure. Innovations include injectable breast augmentation with minimal scarring and fat transfer techniques to enhance breast volume or camouflage implants.
However, cosmetic surgery following weight-loss drug use is not without specific considerations. GLP-1 medications can affect the speed of digestion, which has implications for general anesthesia and pre-operative fasting instructions. Surgeons recommend that patients stabilize their weight for at least six months prior to surgery, as significant weight fluctuations after the procedure can impact the longevity and results of the surgery. Gaining or losing weight post-operation can lead to visible implant edges or thinning of surrounding tissue, compromising the support for implants.